Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.

Tourette syndrome is a neurological condition that has no cure but can be managed with various strategies—some of which are ...

The therapy has shown potential in improving TS symptoms in an open-label Phase ... "Relmada acquires Tourette’s therapy rights from Asarina" was originally created and published by ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Phase 2a trials demonstrated Sepranolone's potential to significantly reduce Tourette symptoms and improve quality of life while maintaining a robust safety profile, making it a promising first ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled ...

Tourette syndrome is currently diagnosed about three ... For female participants, it took an average of three years from when symptoms started to when they were diagnosed, compared to two years ...

(MENAFN- GlobeNewsWire - Nasdaq) Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB ...

Baylen Out Loud star Baylen Dupree is taking a major step with boyfriend Colin Dooley. The 22-year-old influencer was ...

However, girls also were slightly older when their tic symptoms started—about 6.5 years old versus 6 years old for boys, results show. Prompt detection of Tourette syndrome is important to help ...